NEWS & EVENTS

Fairs
PHARM CONNECT CONGRESS
PHARM CONNECT CONGRESS

05 mag 2022


Italvacuum is delighted to participate again in Pharm Connect, Central Europe's leading annual pharmaceutical and biotechnology congress, to be ...

News
<br />
Special Configuration

Special Configuration

11 mar 2022


For an important Italian customer, Italvacuum designed and built a High Vacuum System to meet specific and important process requirements, capable of ...

Fairs
<br />
​Italvacuum: all exhibitions in 2022 

​Italvacuum: all exhibitions in 2022 

09 feb 2022


We are back! Italvacuum staff will be happy to meet you at one of these events in 2022 to present our vacuum technology! Pharm Connect ...

Fairs
Italvacuum to attend PCH Meetings
Italvacuum to attend PCH Meetings

17 nov 2021


Italvacuum will attend PCH Meetings, the 17th International business convention for pharmaceutical, chemical and petrochemical ...

News
Authorized Exporter!
Authorized Exporter!

28 giu 2021


Italvacuum has been granted the status of Authorized Exporter by the Customs Agency. Thanks to this qualification, Italvacuum s.r.l. about vacuum ...

News
Bi Evolution®
Bi Evolution®

06 apr 2021


Italvacuum is pleased to announce that Bi Evolution® trademark has been officially certified and registered by the US Patent and Trademark office, ...

News
Saurus939 carries on!
Saurus939 carries on!

09 mar 2021


Ready to go!! Italvacuum is delivering six new vacuum pumps VVC model to an important indian company in the specialties chemical sector. Despite all ...

Fairs
Italvacuum to attend Chemtech World.ie
Italvacuum to attend Chemtech World.ie

22 feb 2021


Italvacuum is happy to announce its partecipation to the first online edition of ChemTECH World. IE as an exhibitor. It will be an experiential , ...

News
<a><b>Italvacuum ensures the continuity of production activities</b></a>
Italvacuum ensures the continuity of production activities

06 nov 2020


Dear Customers, The global COVID-19 situation, especially in Italy, is again critical and unfortunately, continues to give no respite. We at ...